Logo
x

Search

Subscribe Now

Announces

Boston Scientific to Acquire Devoro for ~$336M

Boston Scientific to Acquire Devoro for ~$336M

  • September 21, 2021
Sandoz Enters into a Commercialization and License Agreement with Bio-Thera to Commercialize BAT1706- a Proposed Biosimilar Avastin (bevacizumab)

Sandoz Enters into a Commercialization and License Agreement with Bio-Thera to Commercialize BAT1706- a Proposed Biosimilar Avasti...

  • September 9, 2021
JW's Relmacabtagene Autoleucel Receives the NMPA's Approval for the Treatment of R/R Large B-Cell Lymphoma in China

JW's Relmacabtagene Autoleucel Receives the NMPA's Approval for the Treatment of R/R Large B-Cell Lymphoma in China

  • September 7, 2021
Novartis Announces Spin-Off of Alcon Eye Care Business on April 9- 2019

Novartis Announces Spin-Off of Alcon Eye Care Business on April 9- 2019

  • March 22, 2019
AbbVie Reports FDA's Hold on All Clinical Trials Evaluating Venclexta/Venclyxto (venetoclax) for Multiple Myeloma

AbbVie Reports FDA's Hold on All Clinical Trials Evaluating Venclexta/Venclyxto (venetoclax) for Multiple Myeloma

  • March 20, 2019
Sun Pharma's SPARC Signs a Research Collaboration with HitGen to Develop Therapies

Sun Pharma's SPARC Signs a Research Collaboration with HitGen to Develop Therapies

  • March 13, 2019
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.